A Study to Investigate Tonlamarsen for the Treatment of Adults With Uncontrolled Hypertension (KARDINAL)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 206 participants.
Also called NCT06864104
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 206 participants
- Sponsor
- Registry
-
NCT06864104
-
- Other papers using this trial's data
- Efficacy of Tonlamarsen in Patients With Uncontrolled Hypertension: The KARDINAL Phase 2 Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT06864104. Randomized; quadruple masking; primary purpose treatment. Start 2025-04-10 (actual); primary completion 2026-01-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Investigate Tonlamarsen for the Treatment of Adults With Uncontrolled Hypertension (KARDINAL)
- Condition
- Hypertension
- Intervention (Drug)
- Tonlamarsen
- Intervention (Drug)
- Placebo
- Lead sponsor
- Kardigan, Inc.
Record details
- Record id
cardio:ct-nct06864104- Content hash
52eb9d60eeb99e95aa386883644ea046ee31ee21e0818cc8c4e3615276606eb7